TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,120 | 3,674 | 2,536 |
Financial expenses | 1 | 10 | 24 |
Earnings before taxes | 3,296 | 4,677 | -2,727 |
EBITDA | 3,234 | 5,570 | -1,622 |
Total assets | 9,612 | 7,222 | 6,201 |
Current assets | 6,564 | 3,291 | 1,405 |
Current liabilities | 1,498 | 74 | 3,889 |
Equity capital | 8,115 | 7,148 | 2,102 |
- share capital | 4 | 5 | 5 |
Employees (average) | 3 | 3 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.4% | 99.0% | 33.9% |
Turnover per employee | 373 | 1,225 | 2,536 |
Profit as a percentage of turnover | 294.3% | 127.3% | -107.5% |
Return on assets (ROA) | 34.3% | 64.9% | -43.6% |
Current ratio | 438.2% | 4447.3% | 36.1% |
Return on equity (ROE) | 40.6% | 65.4% | -129.7% |
Change turnover | -2,256 | 1,184 | 1,755 |
Change turnover % | -67% | 48% | 224% |
Chg. No. of employees | 0 | 2 | 0 |
Chg. No. of employees % | 0% | 200% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.